-
effectivehealthcare.ahrq.gov/sites/default/files/s81.pdf
October 01, 2007 - We grouped these codes into general categories
(eg, coronary/cerebral vascular disease, selected vascular … 34 85 0.60 4.0 2.96 0.0033
Aggregate exposure variable of ICD-9-CM codes for
coronary or cerebral vascular … disease
0.15 41 55 60 0.57 2.3 1.79 0.1093
Aggregate exposure variable of ICD-9-CM codes for
non-vascular … is indicated
0.14 10 24 90 0.57 4.1 2.78 0.0130
Aggregate exposure variable of ICD-9-CM codes for vascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_executive.pdf
January 01, 2016 - The International Society for the Study
of Vascular Anomalies classifies IH as
vascular tumors that … are differentiated
from vascular malformations in several
ways including natural history, cellular … Vascular Anomalies. … The current management of vascular
birthmarks. Pediatr Dermatol 1993 Dec;10(4):311-3. … Benign cutaneous vascular tumors
of infancy: when to worry, what to do.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-library-afib.pdf
November 15, 2018 - indicates cause of death was sudden cardiac death, MI,
unstable angina, or other coronary artery disease; vascular … acute episode of focal or global neurological dysfunction caused by brain,
spinal cord, or retinal vascular … acute episode of focal or global neurological dysfunction caused by brain, spinal
cord, or retinal vascular
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ischemic-stroke-treatment_research-protocol.pdf
February 19, 2010 - vascular accident
17. artery occlusion
18. cerebral ischemia
19. … vascular accident
17. artery occlusion
18. cerebral ischemia
19. … F: 763-783-8463
AngioJet System
Catheter Aspiration
FDA Approved
(510K)
Peripheral vascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/polyunsaturated-fatty-protocol.pdf
January 01, 2024 - Specific cardiovascular events
▪ Myocardial infarction
▪ Coronary heart/artery disease
▪ Peripheral vascular … Lipoprotein profiles
● Evaluations of fatty acid biomarker levels
Key Question 2
● Other cardiac or vascular … 2000 participants;
congestive heart failure outcomes, at least 700 participants; and for peripheral vascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/saturated-fat-replacement-protocol.pdf
January 01, 2024 - Specific cardiovascular events
▪ Myocardial infarction
▪ Coronary heart/artery
disease
▪ Peripheral
vascular … Lipoprotein profiles
● Evaluations of fatty acid biomarker levels
Key Question 2
● Other cardiac or vascular … 2000 participants;
congestive heart failure outcomes, at least 700 participants; and for peripheral vascular
-
effectivehealthcare.ahrq.gov/products/infantile-hemangioma/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
May 16, 2013 - was derived from meta-analysis
of six RCTs.
1 RCT27 No signal
This trial27 reported
one case of vascular … included PV stenosis, cardiac
tamponade, stroke and/or transient ischemic attack,
and peripheral vascular … RFA (n=247; 4 mm tip
or internal irrigated-tip
catheter)
NA Complications
Hematoma of the vascular … n=4,156 pts;
ablation catheter type:
NR)
NA Any complications
Overall rate: 211/4,156 (5.1%)
Vascular … /hemorrhagic events: 28/1,122 (2.5%)
No death, atrio-esophageal fistula, or PV stenosis
Vascular
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
December 15, 2010 - commonly used in
outpatient settings
Dietary supplements
Clinical outcomes
Mortality Peripheral vascular … death
o Specific vascular death (e.g., fatal MI, fatal stroke)
• Ischemic Heart Disease (Coronary … ischemia attack (TIA)
o Carotid artery disease (not measured by IMT or Doppler)
o Other
• Peripheral vascular … the AHRQ Methods Guide35 (for
definitions, please see Section VI):
KQ 1: Mortality (all-cause and vascular … hemorrhagic/ischemic/unspecified stroke), quality of life, hospitalization, arrhythmia, peripheral
vascular
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_clinician.pdf
November 01, 2016 - .
�� Evaluation of outcomes important to patients and
decisionmakers (e.g., quality of life, vascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
August 01, 2013 - [2 points],
Diabetes mellitus, prior Stroke/transient ischemic attack/
thromboembolism [2 points], Vascular … (2 points),
Diabetes mellitus, prior Stroke/transient ischemic attack/thromboembolism (2 points), Vascular … All-cause mortality 1 (6,706) SOE = High
No difference (HR 1.01; 95% CI 0.81 to 1.26)
Death from vascular … = Low
Trend toward a reduction in risk with apixaban
(HR 0.79; 95% CI 0.62 to 1.02)
Death from vascular … points), Diabetes mellitus, prior
Stroke/transient ischemic attack/
thromboembolism (2 points),
Vascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_disposition-comments.pdf
May 29, 2013 - Also, physiologic modifiers, such as anatomy,
differences in vascular wall biology, hemostatic
mechanisms … 1995, the routine use of
statin therapy has reduced morbidity and mortality
from CV and peripheral vascular … Member 4 Summary/Discussion/
Conclusion
Page 144, line 26-may be helpful to again define "high-
risk" vascular … We have deleted the phrase “high-risk
vascular patient” and added phrases the reviewer
correctly identified … Dietary cholesterol and egg yolks: Not for patients at
risk of vascular disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pilot-projects-supplementing-white-paper.pdf
December 01, 2024 - migraines in the general adult population, the literature on the use of triptans excluded patients
with vascular … disease or vascular risk factors as well as pregnant women because of safety
concerns in these two … that fit the inclusion criteria of the AHRQ report and addressed safety of triptans in
patients with vascular … disease or vascular risk factors or pregnant women.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
April 06, 2010 - classified as
macrovascular complications (such as incident coronary artery disease and events, peripheral
vascular … classified as
macrovascular complications (such as incident coronary artery disease and events, peripheral
vascular … o We excluded biologic markers of outcomes, such as vascular endothelial function or carotid intima medial
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
January 15, 2015 - responses through an
imbalance of chemical mediators of vasorelaxation and vasoconstriction, termed vascular … The pathophysiologic changes in coronary artery anatomic structure (including deposition of
plaque), vascular … include those related to
local anesthesia and use of contrast material, as well as infection, local vascular … probable)
• Possible ECG changes (e.g., T-wave, NSTEMI) or nondiagnostic ECG
• Presence of other vascular … nephrogenic systemic fibrosis, contrast-related harms, adverse reactions to drugs
for stress tests), vascular
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
January 01, 2007 - We combined search terms for renal artery stenosis, renal hypertension, and renal
vascular disease, … Tier III
Other comparative studies that compared angioplasty or vascular surgery to medical therapy … Renal artery stenosis: a common
and important problem in patients with peripheral
vascular disease. … Pillay WR, Kan YM, Crinnion JN, Wolfe JH,
Joint Vascular Research Group. … Severity of renal vascular disease predicts
mortality in patients undergoing coronary
angiography.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stent-clopidogrel-practice_research.pdf
March 01, 2009 - Eisenstein reported receiving research grants from Medtronic Vascular. Dr. … and Quality, Proctor and Gamble, Pfizer, Medtronic, Alexion
Pharmaceuticals, Medicure, Medtronic Vascular … Califf reported research grants or
contracts from Abbott Vascular Devices, Advanced Cardiovascular … valvular
heart disease, third heart sound, history of cerebrovascular disease, history of peripheral
vascular
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
September 02, 2016 - [mp=ti, ot, ab, nm, hw, kw, kf, px, rx, ui, an, tx, sh, ct, bt, id,
cc]
62. exp peripheral vascular … (peripheral and vascular and disease$).mp. … statin)
O • Must mention CVD (or BP or lipids) in abstract
• All-cause mortality
• Cerebro/cardio-vascular … stroke/CVA, TIA, unstable angina,
amputation 2° PVD, others
o coronary/cardiac disease
o peripheral vascular … cardiovascular invasive interventions (revascularization)
§ CABG (bypass), PCI (coronary angioplasty), vascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_executive.pdf
August 01, 2016 - may impact the purported CV benefits of n-3
FA, including lipid metabolism, blood pressure (BP) and
vascular … reported in the previous review and expands the scope to
include additional CVD outcomes (peripheral vascular … of quantiles)
Outcomes
• All-cause death
• Cardiovascular (CV), cerebrovascular, and
peripheral vascular … events:
o Fatal vascular events (e.g., due to MI, stroke)
o Total incident vascular events (e.g … � For peripheral vascular disease event,
incident hypertension, MACE, and
revascularization outcomes
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
December 01, 2017 - characteristics (e.g., age; race/
ethnicity; symptoms; menopausal status; imaging
characteristics; vascular … characteristics (e.g., age;
race/ethnicity; symptoms; menopausal status; imaging
characteristics; vascular … Journal of vascular and interventional radiology : JVIR.
2014;25(6):823-832.
14. … Journal of vascular and
interventional radiology : JVIR. 2011;22(9):1229-1235.
16. … Journal of vascular and interventional
radiology : JVIR. 2005;16(11):1431-1437.
24.